杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/03/20 | 1,704 | 1,705 | 1,684 | 1,685 | -19 | -1.1% | 95,800 |
2023/03/17 | 1,717 | 1,723 | 1,704 | 1,704 | +5 | +0.3% | 93,100 |
2023/03/16 | 1,690 | 1,703 | 1,689 | 1,699 | -9 | -0.5% | 82,100 |
2023/03/15 | 1,699 | 1,712 | 1,695 | 1,708 | +14 | +0.8% | 83,400 |
2023/03/14 | 1,693 | 1,699 | 1,678 | 1,694 | -16 | -0.9% | 130,900 |
2023/03/13 | 1,706 | 1,711 | 1,700 | 1,710 | -20 | -1.2% | 74,400 |
2023/03/10 | 1,736 | 1,739 | 1,724 | 1,730 | -10 | -0.6% | 116,000 |
2023/03/09 | 1,720 | 1,740 | 1,719 | 1,740 | +25 | +1.5% | 77,000 |
2023/03/08 | 1,713 | 1,719 | 1,709 | 1,715 | +7 | +0.4% | 53,900 |
2023/03/07 | 1,698 | 1,717 | 1,696 | 1,708 | +16 | +0.9% | 61,600 |
2023/03/06 | 1,700 | 1,701 | 1,683 | 1,692 | -8 | -0.5% | 82,400 |
2023/03/03 | 1,690 | 1,702 | 1,682 | 1,700 | +23 | +1.4% | 113,500 |
2023/03/02 | 1,686 | 1,686 | 1,673 | 1,677 | ±0 | ±0% | 49,500 |
2023/03/01 | 1,693 | 1,693 | 1,671 | 1,677 | -11 | -0.7% | 130,100 |
2023/02/28 | 1,695 | 1,699 | 1,688 | 1,688 | -5 | -0.3% | 109,700 |
2023/02/27 | 1,700 | 1,700 | 1,687 | 1,693 | -1 | -0.1% | 33,600 |
2023/02/24 | 1,700 | 1,700 | 1,688 | 1,694 | +4 | +0.2% | 76,700 |
2023/02/22 | 1,697 | 1,704 | 1,687 | 1,690 | -9 | -0.5% | 69,300 |
2023/02/21 | 1,690 | 1,699 | 1,689 | 1,699 | +9 | +0.5% | 51,000 |
2023/02/20 | 1,690 | 1,692 | 1,687 | 1,690 | +6 | +0.4% | 32,700 |
2023/02/17 | 1,681 | 1,686 | 1,677 | 1,684 | -2 | -0.1% | 75,500 |
2023/02/16 | 1,699 | 1,702 | 1,684 | 1,686 | -10 | -0.6% | 46,400 |
2023/02/15 | 1,700 | 1,703 | 1,688 | 1,696 | +2 | +0.1% | 44,500 |
2023/02/14 | 1,694 | 1,702 | 1,684 | 1,694 | +9 | +0.5% | 32,400 |
2023/02/13 | 1,688 | 1,693 | 1,674 | 1,685 | -3 | -0.2% | 26,100 |
2023/02/10 | 1,675 | 1,699 | 1,675 | 1,688 | -3 | -0.2% | 49,900 |
2023/02/09 | 1,678 | 1,698 | 1,678 | 1,691 | +6 | +0.4% | 37,200 |
2023/02/08 | 1,665 | 1,689 | 1,665 | 1,685 | +18 | +1.1% | 53,000 |
2023/02/07 | 1,715 | 1,715 | 1,666 | 1,667 | -2 | -0.1% | 135,000 |
2023/02/06 | 1,673 | 1,673 | 1,657 | 1,669 | +10 | +0.6% | 64,600 |
2023/02/03 | 1,660 | 1,668 | 1,657 | 1,659 | -14 | -0.8% | 89,600 |
2023/02/02 | 1,703 | 1,707 | 1,671 | 1,673 | -34 | -2% | 103,700 |
2023/02/01 | 1,731 | 1,731 | 1,707 | 1,707 | -13 | -0.8% | 32,200 |
2023/01/31 | 1,719 | 1,723 | 1,709 | 1,720 | +1 | +0.1% | 76,500 |
2023/01/30 | 1,710 | 1,720 | 1,706 | 1,719 | +11 | +0.6% | 62,500 |
2023/01/27 | 1,714 | 1,720 | 1,708 | 1,708 | -3 | -0.2% | 25,100 |
2023/01/26 | 1,714 | 1,717 | 1,708 | 1,711 | -5 | -0.3% | 26,500 |
2023/01/25 | 1,713 | 1,721 | 1,702 | 1,716 | +6 | +0.4% | 58,000 |
2023/01/24 | 1,694 | 1,714 | 1,692 | 1,710 | +16 | +0.9% | 53,700 |
2023/01/23 | 1,697 | 1,710 | 1,692 | 1,694 | +5 | +0.3% | 48,400 |
2023/01/20 | 1,689 | 1,694 | 1,681 | 1,689 | +5 | +0.3% | 31,000 |
2023/01/19 | 1,679 | 1,686 | 1,669 | 1,684 | +8 | +0.5% | 47,200 |
2023/01/18 | 1,654 | 1,683 | 1,653 | 1,676 | +29 | +1.8% | 36,100 |
2023/01/17 | 1,654 | 1,658 | 1,644 | 1,647 | -7 | -0.4% | 43,800 |
2023/01/16 | 1,639 | 1,666 | 1,639 | 1,654 | +8 | +0.5% | 40,300 |
2023/01/13 | 1,655 | 1,664 | 1,643 | 1,646 | -15 | -0.9% | 68,000 |
2023/01/12 | 1,663 | 1,665 | 1,655 | 1,661 | +4 | +0.2% | 37,700 |
2023/01/11 | 1,649 | 1,664 | 1,649 | 1,657 | +12 | +0.7% | 40,600 |
2023/01/10 | 1,663 | 1,675 | 1,645 | 1,645 | -18 | -1.1% | 80,300 |
2023/01/06 | 1,682 | 1,682 | 1,662 | 1,663 | -8 | -0.5% | 60,500 |
501~
550
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 143,100円 | +3.2% | +4.5% | 3.63% | 16.44倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
サンバイオ | 162,700円 | - | - | 0.00% | - | 75.36倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
持田薬 | 301,500円 | +3.0% | +27.5% | 2.65% | 19.09倍 | 0.83倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 174,100円 | +21.7% | +999.9% | 0.00% | 7.25倍 | 2.40倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
栄研化 | 213,600円 | +0.4% | -8.4% | 2.48% | 27.42倍 | 1.55倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム